Skip to main content
. 2020 Jul 28;12(8):2261. doi: 10.3390/nu12082261

Table 2.

Total and direct effects of estimated desaturase activities and risk of type 2 diabetes and coronary artery disease.

T2DM CAD
Method N (SNPs) * OR (95% CI) p-Value N (SNPs) † OR (95% CI) p-Value
D6D instruments from FADS IVW 6 1.08 (1.06–1.09) <0.001 6 1.06 (1.02–1.11) 0.008
MVIVW 10 1.03 (0.94–1.12) 0.528 10 1.00 (0.93–1.07) 0.971
MVIVW ‡ 10 1.03 (0.99–1.16) 10 1.01 (0.91–1.12)
instruments from FADS and genome-wide hits MVIVW 12 1.03 (0.95–1.10) 0.514 12 1.00 (0.95–1.06) 0.907
MVIVW ‡ 12 1.01 (0.94–1.10) 12 1.00 (0.96–1.15)
D5D instruments from FADS IVW 9 1.03 (1.01–1.04) <0.001 9 1.03 (1.01–1.05) 0.017
MVIVW 10 1.00 (0.96–1.04) 0.824 10 1.04 (1.01–1.08) 0.021
MVIVW ‡ 10 1.02 (0.98–1.04) 10 1.04 (1.01–1.15)
instruments from FADS and genome-wide hits IVW 11 1.04 (1.02–1.06) <0.001 11 1.03 (1.01–1.06) 0.017
MVIVW 12 1.00 (0.96–1.03) 0.845 12 1.03 (0.99–1.06) 0.108
MVIVW ‡ 12 1.02 (0.99–1.05) 12 1.04 (0.99–1.07)

CAD, coronary artery disease; CI, confidence interval; D5D, delta-5-desaturase; D6D, delta-6-desaturase; IVW, inverse variance weighted method; MVIVW, multivariable inverse variance weighted method; OR, Odds ratio; T2DM, type 2 diabetes. * Of the 11/7 SNPs associated with D5D/D6D, 11/7 were available in the GWAS of T2DM [18]. After harmonization and removal of palindromic SNPs with intermediate allele frequencies, 9/6 SNPs were included in the MR analysis on T2DM. For MVMR a combined set of 10 SNPs was used. † Of the 11/7 SNPs associated with D5D/D6D, 10/6 were available in the GWAS of CAD [19]. After harmonization and removal of palindromic SNPs with intermediate allele frequencies, 9/6 SNPs were included in the MR analysis on CAD. For MVMR a combined set of 10 SNPs was used. ‡ adjusting for weak instruments in MVMR, but not for correlation structure between instruments.